This application is submitted in response to NOT-TR-20-014 as a supplement to Parent Award UL1TR002489, the North Carolina Translational and Clinical Sciences Institute (NC TraCS). This CTSA Administrative Supplement will add a dedicated quality assurance/quality control position to the NC TraCS Regulatory Knowledge and Support Program to perform quality reviews of CTSA-related submissions to NCATS, submissions to the eRA Human Subjects System, and management of the overall prior approval process. The following specific aims will be addressed by this supplement:
Aim 1 ? Create a dedicated position to oversee and manage internal processes for prior approval requests to NCATS.
Aim 2 ? Implement a comprehensive evaluation strategy to guide decision-making and ensure continuous improvement in processes.

Public Health Relevance

/Relevance The regulatory processes involved in translating biomedical discoveries into clinical applications are complex and evolve rapidly, often creating barriers that hinder the translation of discoveries into products to improve human health. The goal of the CTSA program is to tackle system-wide scientific and operational changes that solve the outstanding problems limiting the efficiency, effectiveness and reach of translational science. This application supports the CTSA goal by improving the accuracy, efficiency, and effectiveness of the regulatory process.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR002489-03S3
Application #
10158836
Study Section
Program Officer
Chang, Soju
Project Start
2018-03-30
Project End
2023-02-28
Budget Start
2020-07-01
Budget End
2021-02-28
Support Year
3
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Sun, Xuezheng; Shan, Yue; Li, Quefeng et al. (2018) Intra-individual Gene Expression Variability of Histologically Normal Breast Tissue. Sci Rep 8:9137
Fioretto, Paola; Del Prato, Stefano; Buse, John B et al. (2018) Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study. Diabetes Obes Metab 20:2532-2540
Inscoe, Christina R; Platin, Enrique; Mauriello, Sally M et al. (2018) Characterization and preliminary imaging evaluation of a clinical prototype stationary intraoral tomosynthesis system. Med Phys 45:5172-5185
Gallaher, Jared R; Banda, Wone; Lachiewicz, Anne M et al. (2018) Colonization with Multidrug-Resistant Enterobacteriaceae is Associated with Increased Mortality Following Burn Injury in Sub-Saharan Africa. World J Surg 42:3089-3096
Buglak, Nicholas E; Jiang, Wulin; Bahnson, Edward S M (2018) Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats. Redox Biol 19:166-178
Qiao, Mu; Truong, Kinh N; Franz, Jason R (2018) Does local dynamic stability during unperturbed walking predict the response to balance perturbations? An examination across age and falls history. Gait Posture 62:80-85
Toles, Mark; Leeman, Jennifer; Colón-Emeric, Cathleen et al. (2018) Implementing a Standardized Transition Care Plan in Skilled Nursing Facilities. J Appl Gerontol :733464818783689
Lund, Jennifer L; Sanoff, Hanna K; Peacock Hinton, Sharon et al. (2018) Potential Medication-Related Problems in Older Breast, Colon, and Lung Cancer Patients in the United States. Cancer Epidemiol Biomarkers Prev 27:41-49
Nel, Jeremy S; Bartelt, Luther A; van Duin, David et al. (2018) Endemic Mycoses in Solid Organ Transplant Recipients. Infect Dis Clin North Am 32:667-685
Turner, Kea; Renfro, Chelsea; Ferreri, Stefanie et al. (2018) Supporting Community Pharmacies with Implementation of a Web-Based Medication Management Application. Appl Clin Inform 9:391-402

Showing the most recent 10 out of 76 publications